NextCell Pharma AB's total assets for Q3 2025 were kr52.21M, a decrease of -15.07% from the previous quarter. DE:65G total liabilities were kr11.12M for the fiscal quarter, a 9.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.